What is the current valuation of the France genomics market in 2024?

The overall market valuation was $2624.26 Million in 2024. Read More

What is the projected market size for the France genomics market by 2035?

The projected valuation for 2035 is $9677.0 Million. Read More

What is the expected CAGR for the France genomics market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 12.6%. Read More

Which application segment had the highest valuation in 2024?

In 2024, the Clinical Diagnostics segment had the highest valuation at $800.0 Million. Read More

What is the projected valuation for the Genetic Testing segment by 2035?

The Genetic Testing segment is projected to reach $3677.0 Million by 2035. Read More

Which technology segment is expected to grow significantly by 2035?

The Sequencing segment is expected to grow significantly, with a projected valuation of $4000.0 Million by 2035. Read More

What role do key players like Illumina and Thermo Fisher Scientific play in the market?

Key players such as Illumina and Thermo Fisher Scientific are instrumental in driving innovation and market growth. Read More

How does the valuation of the Pharmaceutical Companies segment compare to others in 2024?

In 2024, the Pharmaceutical Companies segment was valued at $724.26 Million, indicating strong market presence. Read More

What is the expected growth for the Microarray technology segment by 2035?

The Microarray technology segment is projected to reach $2000.0 Million by 2035. Read More

Which end-use segment is anticipated to have the highest valuation in 2035?

The Hospitals end-use segment is anticipated to have the highest valuation at $3000.0 Million in 2035. Read More

France Genomics Market

ID: MRFR/LS/50705-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

France Genomics Market Research Report: Size, Share, Trend Analysis By Applications (Drug Discovery, Clinical Diagnostics, Personalized Medicine, Genetic Testing), By Technology (Sequencing, Microarray, PCR, CRISPR), andBy End Use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

France Genomics Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)12.6%

2024 Market Size$ 2,624.26 Million

2025 Market Size$ 2,954.92 Million

2035 Market Size$ 9,677 Million

Key Players

Illumina

Thermo Fisher Scientific

Roche

Agilent Technologies

BGI Genomics

Qiagen

Trends

Rise of Personalized Medicine
Advancements in Genomic Technologies
Increased Public Awareness and Acceptance

Opportunities

Growing Investment in Genomic Research
Regulatory Support for Genomic Innovations
Rising Demand for Genetic Testing Services

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Application (USD Million)
  1. 4.1.1 Drug Discovery
  2. 4.1.2 Clinical Diagnostics
  3. 4.1.3 Personalized Medicine
  4. 4.1.4 Genetic Testing
2. 4.2 Chemicals and Materials, BY Technology (USD Million)
  1. 4.2.1 Sequencing
  2. 4.2.2 Microarray
  3. 4.2.3 PCR
  4. 4.2.4 CRISPR
3. 4.3 Chemicals and Materials, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutes
  4. 4.3.4 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Agilent Technologies (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 BGI Genomics (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Qiagen (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 PerkinElmer (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eurofins Scientific (LU)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION
3. 6.3 FRANCE MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 FRANCE MARKET ANALYSIS BY END USE
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
13. 6.13 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

Drug Discovery
Clinical Diagnostics
Personalized Medicine
Genetic Testing

Chemicals and Materials By Technology (USD Million, 2025-2035)

Sequencing
Microarray
PCR
CRISPR

Chemicals and Materials By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”